The ACC has named Melvin R. Echols, MD, FACC, as its new Chief Diversity, Equity and Inclusion Officer
News | ACC
ACC Names Dr. Melvin Echols as Chief Diversity, Equity and Inclusion Officer

July 15, 2022 — The ACC has named Melvin R. Echols, MD, FACC, as its new Chief Diversity, Equity and Inclusion Officer ...

Home July 15, 2022
Home
MMRI Scientist Dr. Nathan Tucker co-authors groundbreaking study with team from The Broad Institute of MIT and Harvard, Bayer AG
News | Cardiovascular Clinical Studies
Molecular Heart Mapping and Cripsr Technology Create New Possibilities for Health Science

July 15, 2022 — Imagine, if scientists had a map of the heart, so granular in its accuracy that it even profiled details ...

Home July 15, 2022
Home
The American Heart Association, the leading voluntary organization devoted to longer, healthier lives, recognizes structural racism as a major cause of poor health and premature death from heart disease and stroke
News | Heart Failure
Winning Scientific Research Announced for Heart Failure and Social/Structural Determinants of Health

July 15, 2022 — The American Heart Association, the leading voluntary organization devoted to longer, healthier lives ...

Home July 15, 2022
Home
This model heart ventricle, made with real living heart cells, beats strongly enough to pump fluid inside a tube. It can be used to study heart disease and test out potential therapies, without the need for invasive surgery.
News | Artificial Heart
Reverse Engineering the Heart: University of Toronto Engineering Team Creates Bioartificial Left Ventricle 

July 14, 2022 — University of Toronto Engineering researchers have grown a small-scale model of a human left heart ...

Home July 14, 2022
Home
More than one in four pregnancy-related deaths (26.5%) in the U.S. are tied to poor heart health, especially among people of color, putting both parents-to-be and their babies at risk, according to the American Heart Association Heart Disease and Stroke Statistics 2022 Update.
News | Womens Cardiovascular Health
$20 Million Awarded for Research to Improve Outcomes in Pregnancy, Infant CVD Health 

July 14, 2022 — More than one in four pregnancy-related deaths (26.5%) in the U.S. are tied to poor heart health ...

Home July 14, 2022
Home
Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has launched a multi-year strategic collaboration with Novartis Pharmaceuticals Corporation (“Novartis”) to deploy a series of artificial intelligence (AI)-powered software solutions that will detect hidden cardiovascular conditions
News | Artificial Intelligence
Anumana Collaborates with Leading Global Health Care Company to Detect Heart Disease Using Artificial Intelligence

July 14, 2022 — Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has launched a ...

Home July 14, 2022
Home
AvoMD and SCCT image
News | Cardiac Imaging
AvoMD Partners with the SCCT to bring guidelines to the point-of-care

July 14, 2022 – AvoMD, a next-generation application-based clinical decision support platform, is working with the ...

Home July 14, 2022
Home
The authors analyzed data about 8,224 children who received cardiac transplants from January 1994 through September 2019. The data came from the Scientific Registry of Transplant Recipients (SRTR), a national database of all organ transplants in the United States. The researchers adjusted their analyses for factors including age, sex, cognitive difficulties, insurance status, transplant year and the reason for heart transplant.
News | Pediatric Cardiology
Study Finds Risk Disparity for Black Children Who Have Stroke After Heart Transplant

July 13, 2022 — Black children who underwent heart transplant surgery for the first time were more than three times as ...

Home July 13, 2022
Home
Adults with abnormal heart metabolism are up to three times more likely to experience life-threatening arrhythmias (an irregular heart rhythm), and MRI techniques could be used to detect the condition and predict future sudden cardiac death (SCD),
News | Sudden Cardiac Arrest
Johns Hopkins Medicine Study: Abnormal Heart Metabolism May Predict Future Sudden Cardiac Death 

July 13, 2022 — Adults with abnormal heart metabolism are up to three times more likely to experience life-threatening ...

Home July 13, 2022
Home
the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the AccuCinch Ventricular Restoration System
News | Heart Failure
Ancora Heart Receives Breakthrough Device Designation from FDA for the AccuCinch Ventricular Restoration System

July 13, 2022 — Ancora Heart, Inc., a company developing a novel device-based therapy to address heart failure, today ...

Home July 13, 2022
Home
July/August 2022 issue of Diagnostic and Interventional Cardiology
Feature | Cardiovascular Business
DAIC's July/August Digital Edition is Now Available

View the July/August digital edition of Diagnostic and Interventional Cardiology (DAIC), including links to videos ...

Home July 13, 2022
Home
Screen Shot 2022-07-13 at 1.10.00 PM
News | SCCT
SCCT Names Finalists for Best Abstract and Canon Young Investigator Awards

July 13, 2022 — Ahead of its 2022 Annual Scientific Meeting, July 15 – 17 in Las Vegas, the Society of Cardiovascular ...

Home July 13, 2022
Home
Screen Shot 2022-07-13 at 12.16.15 PM
News | SCCT | SCCT
Developments in AIU, Plaque Assessment to be Showcased at SCCT2022

July 13, 2022 — The Society of Cardiovascular Computed Tomography (SCCT) has released an update on the device ...

Home July 13, 2022
Home
The BIO REACT study was designed to better understand when and where a stent is needed following drug-coated balloon for the treatment of femoropopliteal artery lesions in patients with peripheral artery disease (PAD)
News | Drug-Eluting Balloons
New Data at LINC 2022 Confirm Passeo-18 Lux Drug-Coated Balloon is a Safe and Effective Treatment in Challenging Patient Groups

July 12, 2022 — Biotronik announced the presentation of two studies on the performance of its drug-coated balloon ...

Home July 12, 2022
Home
A Multi-Disciplinary Group of MedTech Stakeholders Will Convene Just Before the Main Sessions of TCT 2022 to Provide Real-World Insight into Health Technology Advancements, Challenges, and Opportunities
News | TCT
CRF and Fogarty Innovation Launch the “TCT MedTech Innovation Forum”

July 12, 2022 — The Cardiovascular Research Foundation (CRF) and Fogarty Innovation announced today that they are ...

Home July 12, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now